Alexandria Real Estate Equities Inc Dossier
Qualitative Analysis
Business overview
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an S&P 500 urban office real estate investment trust (REIT) that pioneered the life science real estate niche in 1994. The company is the preeminent owner, operator, and developer of collaborative Class A/A+ laboratory and office space concentrated in AAA innovation cluster locations. These premier clusters include Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. Alexandria's core strategy centers on its proprietary Megacampus™ ecosystems, which foster scientific advancement, collaboration, and operational efficiency for a high-quality, diverse tenant base consisting of multinational pharmaceutical companies, public and private biotechnology entities, academic institutions, and government research organizations.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Focusing development and operations on collaborative Megacampus ecosystems in AAA life science innovation clusters (such as Greater Boston, San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City) to drive network effects, tenant stickiness, and premium rent capture.
Expected impact: Insulates the portfolio from broader office market vacancy pressures, supporting high pre-leasing rates (projects expected to deliver from 2Q26 through 4Q26 are 93% leased or negotiating) and contractual revenue growth.
Ramping up asset dispositions and sales of partial interests, specifically targeting non-core assets and land bank reductions, while simultaneously reducing development CapEx and preserving cash through a 45% dividend reduction.
Expected impact: Preserves approximately $410 million in annual liquidity from the dividend cut, provides capital to retire maturing senior notes, and maintains S&P Global Ratings-adjusted debt to EBITDA in the low-to-mid 6x area.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Expansion of the Lilly Gateway Labs platform to San Diego at the One Alexandria Square Megacampus in Torrey Pines. The shared hub combines Alexandria's Class A laboratory infrastructure with Lilly's scientific resources, mentorship, and venture capital network to foster early-stage biotech companies.
Terms: Not explicitly disclosed; located in a LEED Gold certified all-electric laboratory facility.
Longstanding partnership supporting the Naval Special Warfare community, including direct program funding and leadership support for the Warrior Fitness Program. This includes the co-development of a 19,188 square foot specialized physical and mental recovery facility in San Diego.
Terms: Direct program funding and fundraising leadership by Alexandria's executive team.